NATICK, Mass., Nov. 23 /PRNewswire-FirstCall/ -- Boston Scientific Corporation is scheduled to participate in The Fifth Annual Merrill Lynch Med Tech Fundamentals Conference, which is being held on Thursday, December 1st in New York City.
Paul LaViolette, Boston Scientific Chief Operating Officer, will participate in a panel discussion related to Interventional Cardiology beginning at approximately 10:30 a.m. ET.
A live webcast and archived replay of Mr. LaViolette’s remarks will be available to all interested parties at Boston Scientific’s website at http://www.bostonscientific.com in the Investor Relations section. To access the webcast, please click on the “Reports and Webcast” link followed by the “Go to Webcast and Archives” link. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes before the webcast begins.
The replay will be archived and available in the Webcast and Archives section of the Investor Relations site at http://www.bostonscientific.com until December 15, 2005.
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.
CONTACT: Milan Kofol 508-650-8569 Investor Relations Boston Scientific Corporation Paul Donovan 508-650-8541 Media Relations Boston Scientific Corporation
Boston Scientific Corporation
CONTACT: Milan Kofol, +1-508-650-8569, Investor Relations, or PaulDonovan, +1-508-650-8541, Media Relations, both of Boston ScientificCorporation
Web site: http://www.bostonscientific.com//